Related references
Note: Only part of the references are listed.Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
Lei Zha et al.
ADVANCES IN THERAPY (2020)
Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit
Ying Xu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis
Hekun Mei et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases A meta-analysis
Jinhong Gong et al.
MEDICINE (2019)
Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens
Zihan Chen et al.
MEDICINE (2018)
Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
Mark H. Gotfried et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections
Jiao Xie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid
J. G. Coen van Hasselt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia
Li Xu et al.
CHEMOTHERAPY (2015)
Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women
Kevin P. Connors et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens
Garyphallia Poulakou et al.
FUTURE MICROBIOLOGY (2014)
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
Gennaro De Pascale et al.
CRITICAL CARE (2014)
Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
Julio Ramirez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials
Paul C. McGovern et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline
Sujata M. Bhavnani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Antonio T. Freire et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Pharmacodynamics of Tigecycline against Phenotypically Diverse Staphylococcus aureus Isolates in a Murine Thigh Model
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Matthew E. Falagas et al.
CURRENT DRUG METABOLISM (2009)
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Olaf Burkhardt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs
Jared L. Crandon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation
Christopher M. Rubino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections
A. K. Meagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia
TR Fritsche et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
JE Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Share Paper
